(Q38443643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Prescribing trends in cognition enhancing drugs in Australia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

Samantha A. Hollingworth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Gerard J Byrne

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

30 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

International Psychogeriatrics

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

238-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Effect of a training programme to reduce stress in carers of patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Donepezil for the treatment of agitation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

A population-based study of cholinesterase inhibitor use for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

High prevalence of dementia and cognitive impairment in Indigenous Australians

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Prevalence of cholinesterase inhibitors in subjects with dementia in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

Cholinesterase inhibitors for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210001146

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1041610210001146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670461%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference